Sharon Benzeno $ADPT SEC Form 4 Insider Trading

Sharon Benzeno has filed a total of 12 insider trades in $ADPT since 2021. Their most recent trade was a sale of 154,768 shares, made on Jun 29, 2026. Their largest trade was a sale of 308,477 shares, made on Nov 21, 2025. We estimate that they now own 274,588 shares of $ADPT, worth an estimated $6.0 million.

Insider Trading at $ADPT

There have been a total of 276 insider trades reported at $ADPT since 2021, with 0 shares purchased and 8.4 million shares sold. The most active insider traders in $ADPT stock have been Harlan S Robins, Julie Rubinstein, and Chad M Robins. The most recent trade was a sale of 213,702 shares reported by HARLAN S ROBINS (Chief Scientific Officer), made on Jul 21, 2026.

$ADPT Executives and Stock Owners with Insider Trades

• Harlan S Robins, Chief Scientific Officer

• Julie Rubinstein, President and COO

• Chad M Robins, CEO and Chairman

• R Mark Adams, Chief Operating Officer

• Francis Lo, Chief People Officer

• Chad M Cohen, Chief Financial Officer

• Stacy L Taylor, SVP and General Counsel

• Kyle Piskel, Chief Financial Officer

• Sharon Benzeno, Chief Commercial Ofc Imm Med

• Susan Bobulsky, Chief Commercial Officer, MRD

• Kyle Piskel, Principal Accounting Officer

• Nitin Sood, Chief Commercial Officer, MRD

• Tycho Peterson, Chief Financial Officer

• Julie Rubinstein, President

• Jyoti Palaniappan, SVP, Diagnostics, T-Detect

• Lance Baldo, Chief Medical Officer

• Sharon Benzeno, Chief Business Development Off

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.